Exact Mass: 616.4342

Crassostrea Secocarotenoid

C40H56O5 (616.4128)

Crassostrea Secocarotenoid is found in mollusks. Crassostrea Secocarotenoid is a constituent of the oyster Crassostrea gigas. Constituent of the oyster Crassostrea gigas. Crassostrea Secocarotenoid is found in mollusks.

(3S,3'S,5R,5'R,6R)-6,7-Didehydro-5,6-dihydro-3,3',5,8'-tetrahydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

(3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one is found in mollusks. (3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one is a constituent of the oyster Crassostrea gigas. Constituent of the oyster Crassostrea gigas. (3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one is found in mollusks.

Tsugarioside B

C37H60O7 (616.4339)

Tsugarioside B is found in mushrooms. Tsugarioside B is a constituent of Ganoderma tsugae (red reishi) Constituent of Ganoderma tsugae (red reishi). Tsugarioside B is found in mushrooms.

Oryzanol C

C41H60O4 (616.4491)

Oryzanol C is from rice bran oi From rice bran oil

Nonoxynol-9

C33H60O10 (616.4186)

Nonoxynol-9 (N-9) is a typical surfactant used as a vaginal spermicide. Spermicides are locally acting non-hormonal contraceptives. When present in the vagina during intercourse, they immobilize/inactivate/damage and/or kill sperms without eliciting systemic effects. N-9 has been in use for more than 30 years as an over-the-counter (OTC) drug in creams, gels, foams and condom lubricants. It is the most commonly used spermicidal contraceptive in the UK and the USA. In several European countries, spermicides are no longer on the market. D009676 - Noxae > D000988 - Antispermatogenic Agents > D013089 - Spermatocidal Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

(3S,3'S,5R,5'R,6R)-3,6-Epoxy-5,6-dihydro-3',5,8'-trihydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

(3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one is found in mollusks. (3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one is a constituent of the oyster Crassostrea gigas. Constituent of the oyster Crassostrea gigas. (3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one is found in mollusks.

PA(16:1(9Z)/14:1(9Z))

C33H61O8P (616.4104)

PA(16:1(9Z)/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:1(9Z)/14:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/18:2(9Z,11Z))

C33H61O8P (616.4104)

PA(i-12:0/18:2(9Z,11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/18:2(9Z,11Z)), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Fucoxanthinol

C40H56O5 (616.4128)

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0)

C38H64O6 (616.4703)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0)

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0)

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0)

C38H64O6 (616.4703)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0)

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0)

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0)

C38H64O6 (616.4703)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0)

C38H64O6 (616.4703)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Oryzanol B

C41H60O4 (616.4491)

Oryzanol b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Oryzanol b can be found in rice, which makes oryzanol b a potential biomarker for the consumption of this food product.

hedyotisol A

C41H60O4 (616.4491)

3,4,3,8-Tetrahydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

Sugikurojin J

C40H56O5 (616.4128)

Bacchalatiofolin

C38H64O6 (616.4703)

Vaucheriaxanthin

C40H56O5 (616.4128)

Isofucoxanthinol

C40H56O5 (616.4128)

Cyclomytiloxanthin

C40H56O5 (616.4128)

Fucoxanthinol

C40H56O5 (616.4128)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

C37H60O7

C37H60O7 (616.4339)

argentinic acid A methyl ester

C37H60O7 (616.4339)

C(19)-Obtusilacton dimer

C38H64O6 (616.4703)

Inundoside B

C37H60O7 (616.4339)

Crytomeria acetal B

C40H56O5 (616.4128)

cholest-14-ene-3,7,24,25-tetrol-21,23-epoxy-21-methoxy-4,4,8-trimethyl-3-(3-methyl-2-butenoate)

C37H60O7 (616.4339)

cyclomargenyl-3-O-beta-caffeoyl ester

C41H60O4 (616.4491)

(3S,4R)-3,4-dihydroxy-3,6-epoxy-1,2,5,6,7,8-hexahydro-6-methyl-16-nor-beta,phi-carotene-1,8-dione|3,4-Dihydroxy-3,6-epoxy-1,2,5,67,8-hexahydro-6-methyl-16-nor-??,搂脗-carotene-1,8-dione

C40H56O5 (616.4128)

cyclobranyl ferulate

C41H60O4 (616.4491)

C40H56O5

C40H56O5 (616.4128)

C38H64O6

C38H64O6 (616.4703)

Oryzanol C

C41H60O4 (616.4491)

Oryzanol C is a triterpenoid. 24-Methylenecycloartanyl ferulate is a γ-oryzanol compound. 24-Methylenecycloartanyl ferulate promotes parvin-beta expression in human breast cancer cells. 24-Methylenecycloartanyl ferulate is a potential ATP-competitive Akt1 inhibitor (EC50= 33.3μM)[1]. 24-Methylenecycloartanyl ferulate is a γ-oryzanol compound. 24-Methylenecycloartanyl ferulate promotes parvin-beta expression in human breast cancer cells. 24-Methylenecycloartanyl ferulate is a potential ATP-competitive Akt1 inhibitor (EC50= 33.3μM)[1]. 24-Methylenecycloartanyl ferulate is a γ-oryzanol compound. 24-Methylenecycloartanyl ferulate promotes parvin-beta expression in human breast cancer cells. 24-Methylenecycloartanyl ferulate is a potential ATP-competitive Akt1 inhibitor (EC50= 33.3μM)[1].

6-Hydroxysiphonaxanthin

C40H56O5 (616.4128)

nonoxynol-9

C33H60O10 (616.4186)

PA(12:0/18:2(9Z,12Z))

C33H61O8P (616.4104)

PA(13:0/17:2(9Z,12Z))

C33H61O8P (616.4104)

PA(14:1(9Z)/16:1(9Z))

C33H61O8P (616.4104)

PA(15:1(9Z)/15:1(9Z))

C33H61O8P (616.4104)

PA(16:1(9Z)/14:1(9Z))

C33H61O8P (616.4104)

PA(17:2(9Z,12Z)/13:0)

C33H61O8P (616.4104)

PA(18:2(9Z,12Z)/12:0)

C33H61O8P (616.4104)

PA(P-16:0/15:1(9Z))

C34H65O7P (616.4468)

Tsugarioside B

C37H60O7 (616.4339)

Crassostrea Secocarotenoid

C40H56O5 (616.4128)

(3S,3'S,5R,5'R,6R)-3,6-Epoxy-5,6-dihydro-3',5,8'-trihydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

(3S,3'S,5R,5'R,6R)-6,7-Didehydro-5,6-dihydro-3,3',5,8'-tetrahydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

PA 30:2

C33H61O8P (616.4104)

PA O-31:2

C34H65O7P (616.4468)

(3R,5R,6S,3R,5R,6S)-3,6-Epoxy-5-hydroxy-1,2,5,6,7,8-hexahydro-16-nor-beta,psi-carotene-1,8-dione

C40H56O5 (616.4128)

(3R,3R,5S)-3,3,5,19-tetrahydroxy-7,8-didehydro-gamma,epsilon-carotene-8-one

C40H56O5 (616.4128)

(3S,5R,6S,3S,5R)-3,6-Epoxy-5,3,8-triihydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

Allenicmytiloxanthin

C40H56O5 (616.4128)

Pergascript Red I 6B

C42H52N2O2 (616.4029)

Cyclocrassostreaxanthin A

C40H56O5 (616.4128)

1-Myristoyl-2-palmitoleoyl phosphatidate

C33H61O8P-2 (616.4104)

Fucoxanthinol, (all-trans)-

C40H56O5 (616.4128)

(2Z,5E,7E,9E,11E,13E,15E,17Z)-19-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethyl-1-oxononadeca-2,5,7,9,11,13,15,17-octaen-3-olate

C40H56O5 (616.4128)

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

C38H64O6 (616.4703)

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

C38H64O6 (616.4703)

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

C38H64O6 (616.4703)

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

C38H64O6 (616.4703)

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

C38H64O6 (616.4703)

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

C38H64O6 (616.4703)

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

C38H64O6 (616.4703)

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

C38H64O6 (616.4703)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

C38H64O6 (616.4703)

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

C38H64O6 (616.4703)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

C37H60O7 (616.4339)

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

C37H60O7 (616.4339)

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

C37H60O7 (616.4339)

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

C37H60O7 (616.4339)

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

C37H60O7 (616.4339)

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

C37H60O7 (616.4339)

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

C37H60O7 (616.4339)

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

C37H60O7 (616.4339)

[(16R)-7,7,12,16-tetramethyl-15-(6-methyl-5-methylideneheptan-2-yl)-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C41H60O4 (616.4491)

1-Oleoyl-2-lauroyl-sn-glycero-3-phosphate(2-)

C33H61O8P-2 (616.4104)

N-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3R,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3R,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

N-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)

(3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

NAGlySer 20:5/10:0

C35H56N2O7 (616.4087)

NAGlySer 18:5/12:0

C35H56N2O7 (616.4087)

NAGlySer 16:4/14:1

C35H56N2O7 (616.4087)

Mgdg O-16:1_9:0

C34H64O9 (616.455)

Mgdg O-20:1_5:0

C34H64O9 (616.455)

Mgdg O-8:0_17:1

C34H64O9 (616.455)

Mgdg O-17:1_8:0

C34H64O9 (616.455)

Mgdg O-9:0_16:1

C34H64O9 (616.455)

Mgdg O-21:1_4:0

C34H64O9 (616.455)

Mgdg O-19:1_6:0

C34H64O9 (616.455)

Mgdg O-22:1_3:0

C34H64O9 (616.455)

Mgdg O-18:1_7:0

C34H64O9 (616.455)

Mgdg O-13:1_12:0

C34H64O9 (616.455)

Mgdg O-14:1_11:0

C34H64O9 (616.455)

Mgdg O-12:0_13:1

C34H64O9 (616.455)

Mgdg O-15:1_10:0

C34H64O9 (616.455)

Mgdg O-11:0_14:1

C34H64O9 (616.455)

Mgdg O-10:0_15:1

C34H64O9 (616.455)

PE-Cer 12:1;2O/19:1

C33H65N2O6P (616.458)

PE-Cer 15:2;2O/16:0

C33H65N2O6P (616.458)

PE-Cer 19:2;2O/12:0

C33H65N2O6P (616.458)

PE-Cer 15:0;2O/16:2

C33H65N2O6P (616.458)

PE-Cer 16:1;2O/15:1

C33H65N2O6P (616.458)

PE-Cer 17:1;2O/14:1

C33H65N2O6P (616.458)

PE-Cer 12:2;2O/19:0

C33H65N2O6P (616.458)

PE-Cer 13:0;2O/18:2

C33H65N2O6P (616.458)

PE-Cer 14:1;2O/17:1

C33H65N2O6P (616.458)

PE-Cer 13:1;2O/18:1

C33H65N2O6P (616.458)

PE-Cer 15:1;2O/16:1

C33H65N2O6P (616.458)

PE-Cer 12:0;2O/19:2

C33H65N2O6P (616.458)

PE-Cer 14:0;2O/17:2

C33H65N2O6P (616.458)

PE-Cer 14:2;2O/17:0

C33H65N2O6P (616.458)

PE-Cer 18:2;2O/13:0

C33H65N2O6P (616.458)

PE-Cer 17:2;2O/14:0

C33H65N2O6P (616.458)

PE-Cer 16:2;2O/15:0

C33H65N2O6P (616.458)

PE-Cer 13:2;2O/18:0

C33H65N2O6P (616.458)

PE-Cer 18:1;2O/13:1

C33H65N2O6P (616.458)

PE-Cer 18:3;2O/12:0;O

C32H61N2O7P (616.4216)

PE-Cer 14:3;2O/16:0;O

C32H61N2O7P (616.4216)

PE-Cer 12:2;2O/18:1;O

C32H61N2O7P (616.4216)

PE-Cer 18:2;2O/12:1;O

C32H61N2O7P (616.4216)

PE-Cer 15:2;2O/15:1;O

C32H61N2O7P (616.4216)

PE-Cer 17:3;2O/13:0;O

C32H61N2O7P (616.4216)

PE-Cer 12:1;2O/18:2;O

C32H61N2O7P (616.4216)

PE-Cer 15:3;2O/15:0;O

C32H61N2O7P (616.4216)

PE-Cer 17:2;2O/13:1;O

C32H61N2O7P (616.4216)

PE-Cer 16:2;2O/14:1;O

C32H61N2O7P (616.4216)

PE-Cer 14:1;2O/16:2;O

C32H61N2O7P (616.4216)

PE-Cer 16:3;2O/14:0;O

C32H61N2O7P (616.4216)

PE-Cer 14:2;2O/16:1;O

C32H61N2O7P (616.4216)

[(4E,8E)-2-acetamido-3-hydroxyhexacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(nonanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-2-(butanoylamino)-3-hydroxytetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(propanoylamino)pentacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(octanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(pentanoylamino)tricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-2-(hexanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-2-(heptanoylamino)-3-hydroxyhenicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-2-(decanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(undecanoylamino)heptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-2-(hexadecanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

PMeOH 14:1_15:1

C33H61O8P (616.4104)

PEtOH 12:0_16:2

C33H61O8P (616.4104)

PMeOH 13:1_16:1

C33H61O8P (616.4104)

PEtOH 13:1_15:1

C33H61O8P (616.4104)

PMeOH 12:0_17:2

C33H61O8P (616.4104)

PEtOH 14:1_14:1

C33H61O8P (616.4104)

PMeOH 13:0_16:2

C33H61O8P (616.4104)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-icos-11-enoate

C33H60O10 (616.4186)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-docos-13-enoate

C33H60O10 (616.4186)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C33H60O10 (616.4186)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C33H60O10 (616.4186)

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C33H60O10 (616.4186)

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-octadec-9-enoate

C33H60O10 (616.4186)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-henicos-11-enoate

C33H60O10 (616.4186)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C33H60O10 (616.4186)

[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C33H60O10 (616.4186)

[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tridec-9-enoate

C33H60O10 (616.4186)

[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(4E,8E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

(1-butanoyloxy-3-phosphonooxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

C33H61O8P (616.4104)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C33H61O8P (616.4104)

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C33H61O8P (616.4104)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C33H61O8P (616.4104)

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C33H61O8P (616.4104)

[2-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (Z)-pentadec-9-enoate

C33H61O8P (616.4104)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C33H61O8P (616.4104)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C33H61O8P (616.4104)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C33H61O8P (616.4104)

[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

(3E,5E,7E,9E,11E,13E,15E,17E)-1-[(2S,3R,5R)-2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-18-[(1S,2S,4R)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-hexadec-9-enoate

C33H61O8P (616.4104)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-hexadec-7-enoate

C33H61O8P (616.4104)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-hexadec-7-enoate

C33H61O8P (616.4104)

[(2S,3R,4E,6E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(2S,3R,4E,8E)-2-(decanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (11E,14E)-icosa-11,14-dienoate

C33H61O8P (616.4104)

[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (5E,8E)-icosa-5,8-dienoate

C33H61O8P (616.4104)

[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-tetradec-9-enoate

C33H60O10 (616.4186)

[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (6E,9E)-octadeca-6,9-dienoate

C33H61O8P (616.4104)

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (9E,12E)-octadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2S,3R,4E,6E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (E)-tetradec-9-enoate

C33H60O10 (616.4186)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2S,3R,4E,6E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (9E,11E)-octadeca-9,11-dienoate

C33H61O8P (616.4104)

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

C33H61O8P (616.4104)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (E)-pentadec-9-enoate

C33H61O8P (616.4104)

[(2S,3R,4E,14E)-2-(decanoylamino)-3-hydroxyoctadeca-4,14-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-hexadec-9-enoate

C33H61O8P (616.4104)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (5E,8E)-icosa-5,8-dienoate

C33H61O8P (616.4104)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

C33H61O8P (616.4104)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (2E,4E)-octadeca-2,4-dienoate

C33H61O8P (616.4104)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

C33H61O8P (616.4104)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (4E,7E)-hexadeca-4,7-dienoate

C33H61O8P (616.4104)

[3-[3-butanoyloxy-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C36H58NO7+ (616.4213)

2-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)

2-[[2-heptanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)

2-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)

2-[carboxy-[3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium

C36H58NO7+ (616.4213)

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)

2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)

Nonoxynol 9

C33H60O10 (616.4186)

D009676 - Noxae > D000988 - Antispermatogenic Agents > D013089 - Spermatocidal Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

1-(9Z-hexadecenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C33H61O8P (616.4104)

(3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

1-Oleoyl-2-lauroyl-sn-glycero-3-phosphate(2-)

C33H61O8P (616.4104)

A 1,2-diacyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoyl-2-lauroyl-sn-glycero-3-phosphate.

BisMePA(28:2)

C33H61O8P (616.4104)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 15:3/O-26:7

C41H60O4 (616.4491)

FAHFA 15:4/O-26:6

C41H60O4 (616.4491)

FAHFA 15:5/O-26:5

C41H60O4 (616.4491)

FAHFA 16:3/O-25:7

C41H60O4 (616.4491)

FAHFA 16:4/O-25:6

C41H60O4 (616.4491)

FAHFA 16:5/O-25:5

C41H60O4 (616.4491)

FAHFA 17:3/O-24:7

C41H60O4 (616.4491)

FAHFA 17:4/O-24:6

C41H60O4 (616.4491)

FAHFA 17:5/O-24:5

C41H60O4 (616.4491)

FAHFA 18:3/O-23:7

C41H60O4 (616.4491)

FAHFA 18:4/O-23:6

C41H60O4 (616.4491)

FAHFA 18:5/O-23:5

C41H60O4 (616.4491)

FAHFA 18:6/O-23:4

C41H60O4 (616.4491)

FAHFA 19:3/O-22:7

C41H60O4 (616.4491)

FAHFA 19:4/O-22:6

C41H60O4 (616.4491)

FAHFA 19:5/O-22:5

C41H60O4 (616.4491)

FAHFA 19:6/O-22:4

C41H60O4 (616.4491)

FAHFA 20:3/O-21:7

C41H60O4 (616.4491)

FAHFA 20:4/O-21:6

C41H60O4 (616.4491)

FAHFA 20:5/O-21:5

C41H60O4 (616.4491)

FAHFA 20:6/O-21:4

C41H60O4 (616.4491)

FAHFA 21:4/O-20:6

C41H60O4 (616.4491)

FAHFA 21:5/O-20:5

C41H60O4 (616.4491)

FAHFA 21:6/O-20:4

C41H60O4 (616.4491)

FAHFA 21:7/O-20:3

C41H60O4 (616.4491)

FAHFA 22:4/O-19:6

C41H60O4 (616.4491)

FAHFA 22:5/O-19:5

C41H60O4 (616.4491)

FAHFA 22:6/O-19:4

C41H60O4 (616.4491)

FAHFA 22:7/O-19:3

C41H60O4 (616.4491)

FAHFA 23:4/O-18:6

C41H60O4 (616.4491)

FAHFA 23:5/O-18:5

C41H60O4 (616.4491)

FAHFA 23:6/O-18:4

C41H60O4 (616.4491)

FAHFA 23:7/O-18:3

C41H60O4 (616.4491)

FAHFA 24:5/O-17:5

C41H60O4 (616.4491)

FAHFA 24:6/O-17:4

C41H60O4 (616.4491)

FAHFA 24:7/O-17:3

C41H60O4 (616.4491)

FAHFA 25:5/O-16:5

C41H60O4 (616.4491)

FAHFA 25:6/O-16:4

C41H60O4 (616.4491)

FAHFA 25:7/O-16:3

C41H60O4 (616.4491)

FAHFA 26:5/O-15:5

C41H60O4 (616.4491)

FAHFA 26:6/O-15:4

C41H60O4 (616.4491)

FAHFA 26:7/O-15:3

C41H60O4 (616.4491)

FAHFA 41:10;O

C41H60O4 (616.4491)

MGDG 10:0_14:1

C33H60O10 (616.4186)

MGDG 24:1

C33H60O10 (616.4186)

MGDG O-24:2;O

C33H60O10 (616.4186)

MGDG O-25:1

C34H64O9 (616.455)

MGMG 25:1

C34H64O9 (616.455)

MGGA 24:1

C33H60O10 (616.4186)

PA O-14:0/17:2

C34H65O7P (616.4468)

PA O-14:1/17:1

C34H65O7P (616.4468)

PA O-16:1/15:1

C34H65O7P (616.4468)

PA O-16:2/15:0

C34H65O7P (616.4468)

PA O-18:0/12:3;O

C33H61O8P (616.4104)

PA O-18:2/13:0

C34H65O7P (616.4468)

PA O-20:2/11:0

C34H65O7P (616.4468)

PA O-30:3;O

C33H61O8P (616.4104)

PA P-14:0/17:1

C34H65O7P (616.4468)

PA P-14:0/17:1 or PA O-14:1/17:1

C34H65O7P (616.4468)

PA P-16:0/15:1

C34H65O7P (616.4468)

PA P-16:0/15:1 or PA O-16:1/15:1

C34H65O7P (616.4468)

PA P-16:1/15:0

C34H65O7P (616.4468)

PA P-16:1/15:0 or PA O-16:2/15:0

C34H65O7P (616.4468)

PA P-18:1/13:0

C34H65O7P (616.4468)

PA P-18:1/13:0 or PA O-18:2/13:0

C34H65O7P (616.4468)

PA P-20:1/11:0

C34H65O7P (616.4468)

PA P-20:1/11:0 or PA O-20:2/11:0

C34H65O7P (616.4468)

PA P-31:1

C34H65O7P (616.4468)

PA P-31:1 or PA O-31:2

C34H65O7P (616.4468)

PA 10:0_20:2

C33H61O8P (616.4104)

PA 12:0_18:2

C33H61O8P (616.4104)

PA 13:0_17:2

C33H61O8P (616.4104)

PA 14:1_16:1

C33H61O8P (616.4104)

PA 15:1/15:1

C33H61O8P (616.4104)

PA 26:1/4:1

C33H61O8P (616.4104)

PA 26:2/4:0

C33H61O8P (616.4104)

LPEth 29:2

C34H65O7P (616.4468)

LPM 30:2

C34H65O7P (616.4468)

PEth 28:2

C33H61O8P (616.4104)

PM 29:2

C33H61O8P (616.4104)

6'-Hydroxysiphonaxanthin

C40H56O5 (616.4128)

Hydroxysiphonaxanthin

C40H56O5 (616.4128)

CerPE 14:0;O2/17:2

C33H65N2O6P (616.458)

CerPE 14:1;O2/17:1

C33H65N2O6P (616.458)

CerPE 14:2;O2/17:0

C33H65N2O6P (616.458)

CerPE 15:1;O2/16:1

C33H65N2O6P (616.458)

CerPE 15:2;O2/16:0

C33H65N2O6P (616.458)

CerPE 16:1;O2/15:1

C33H65N2O6P (616.458)

CerPE 16:2;O2/15:0

C33H65N2O6P (616.458)

CerPE 17:1;O2/14:1

C33H65N2O6P (616.458)

CerPE 17:2;O2/14:0

C33H65N2O6P (616.458)

CerPE 18:2;O2/13:0

C33H65N2O6P (616.458)

CerPE 19:2;O2/12:0

C33H65N2O6P (616.458)

CerPE 20:2;O2/11:0

C33H65N2O6P (616.458)

CerPE 21:2;O2/10:0

C33H65N2O6P (616.458)

CerPE 31:2;O2

C33H65N2O6P (616.458)

SM 14:1;O2/14:1

C33H65N2O6P (616.458)

SM 14:2;O2/14:0

C33H65N2O6P (616.458)

SM 15:2;O2/13:0

C33H65N2O6P (616.458)

SM 16:2;O2/12:0

C33H65N2O6P (616.458)

SM 17:2;O2/11:0

C33H65N2O6P (616.458)

SM 18:2;O2/10:0

C33H65N2O6P (616.458)

SM 28:2;O2

C33H65N2O6P (616.458)

SM 8:0;O2/20:2

C33H65N2O6P (616.458)

(3s,3as,5ar,6r,7r,9r,9ar)-7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl (2r,3r)-2-hydroxy-3-methylpentanoate

C37H60O7 (616.4339)

(2z,4e,6e,8e,10e,12e,14e,16e)-19-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

3-hydroxy-15-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)

3a,6,6,9a,11a-pentamethyl-1-{6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)

(2z,4e,6e,8e,10e,12e,14e,16e,18e)-19-[(3r,4s)-3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

(3e,5e,7e,9e,11e,13e,15z)-18-[(2s,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(3s,4ar,6bs,8as,11r,12ar,12bs,14bs)-11-(hydroxymethyl)-4,4,6b,8a,11,12b,14b-heptamethyl-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H56O5 (616.4128)

[(2r)-5-oxo-1,4-dioxacyclooctacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C37H60O7 (616.4339)

1-[2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-18-{2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl}-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

3,4,3',8'-tetrahydroxy-β,κ-caroten-6'-one

C40H56O5 (616.4128)

{"Ingredient_id": "HBIN007214","Ingredient_name": "3,4,3',8'-tetrahydroxy-\u03b2,\u03ba-caroten-6'-one","Alias": "NA","Ingredient_formula": "C40H56O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21069","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3,4-dihydroxy-3',6'-epoxy-1',2',5',6'7',8'-hexa-hydro-6'-methyl-16'-nor-β, φ-carotene-1',8'-dione

C40H56O5 (616.4128)

{"Ingredient_id": "HBIN007376","Ingredient_name": "3,4-dihydroxy-3',6'-epoxy-1',2',5',6'7',8'-hexa-hydro-6'-methyl-16'-nor-\u03b2, \u03c6-carotene-1',8'-dione","Alias": "NA","Ingredient_formula": "C40H56O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5873","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2z,4e,6e,8e,10e,12e,14z,16e,18e)-19-[(3r,4s)-3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

11-(hydroxymethyl)-4,4,6b,8a,11,12b,14b-heptamethyl-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H56O5 (616.4128)

18-(3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-1-[2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(2z,4e,6e,8e,10e)-19-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-3-hydroxy-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

4-{[(4e)-12,13-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl]oxy}-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

(1s,2s)-2-{2-[(2s,3ar,3bs,7as,11br)-9-hydroxy-10-isopropyl-4,4,7a-trimethyl-2h,3ah,3bh,5h,6h,7h,11bh-phenanthro[9,10-d][1,3]dioxol-2-yl]-5-hydroxy-4-isopropylphenyl}-2,6,6-trimethylcyclohexane-1-carbaldehyde

C40H56O5 (616.4128)

7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl 2-hydroxy-3-methylpentanoate

C37H60O7 (616.4339)

2-(5-hydroxy-2-{9-hydroxy-10-isopropyl-4,4,7a-trimethyl-2h,3ah,3bh,5h,6h,7h,11bh-phenanthro[9,10-d][1,3]dioxol-2-yl}-4-isopropylphenyl)-2,6,6-trimethylcyclohexane-1-carbaldehyde

C40H56O5 (616.4128)

(1r,3ar,5as,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2s,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)

(4as,9r,10as)-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl (1r,4ar,4br,7r,10ar)-7-ethenyl-1,4a,7-trimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboperoxoate

C40H56O5 (616.4128)

(3e,5e,7e,9e,11e,13e,15e)-1-[(1e,2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(2z,4e,6e,8e,10e)-3-hydroxy-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-19-{2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl}-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

(3e,5e,7e,9e,11e,13e,15e)-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(3e,5e,7e,9e,11e,13e,15e,17e)-1-[(2s,3r,5r)-2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-18-[(1r,2r,4s)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl 7-ethenyl-1,4a,7-trimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboperoxoate

C40H56O5 (616.4128)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)

(5-oxo-1,4-dioxacyclooctacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C37H60O7 (616.4339)

1,7,7,11,16,20,20-heptamethyl-19-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C37H60O7 (616.4339)

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)

(3e,5e,7e,9e,11e,13e,15e)-18-[(2r,4r)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4r,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(3r,4s)-3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-1-[(2s,3r,5r)-2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

4-{[(4e)-13,14-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl]oxy}-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

(3e,5e,7e,9e)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-1-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

4-[(13,14-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl)oxy]-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)

(3e,5e,7e,9e,11e,13e,15e)-18-[(2s,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(2z,4e,6e,8e,10e)-19-(3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3-hydroxy-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

4-[(12,13-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl)oxy]-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

(2z,4e,6e,8e,10e,12e,14e,16e,18e)-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-19-[(1r,2r,4s)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

(1r,3s,3ar,5ar,7r,9as,11ar)-3-hydroxy-1-[(2r)-1-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl 1-methyl (3s)-3-hydroxy-3-methylpentanedioate

C37H60O7 (616.4339)

(1s,6r,8s,11r,12s,15s,16r,19s,21r)-1,7,7,11,16,20,20-heptamethyl-19-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C37H60O7 (616.4339)